Isfahan University of Medical Sciences

Science Communicator Platform

Share By
A Case-Control Study of the Association of Novel Androgens (11-Kt and Dht), Classical Androgens (Testosterone and Dheas), Hormones (Lh, Fsh, 17-Ohp, Insulin, and Shbg), Insulin Resistance (Homa-Ir), and Dyslipidemia in Polycystic Ovarian Syndrome (Pcos) Publisher

Summary: Novel androgens 11-KT and DHT show potential for PCOS diagnosis, correlating well with standard markers. Could they change evaluation? #PCOS #Androgens

Kumar N ; Sharma N ; Roy S ; Chawla I ; Sharma LK
Authors

Source: Advanced Biomedical Research Published:2025


Abstract

Background: The measurement of androgens (testosterone and dehydroepiandrosterone sulfate (DHEAS)) remains standard for the evaluation of polycystic ovarian syndrome (PCOS) women. However, other early novel androgen markers, 5 alpha-dihydrotestosterone (DHT) and 11-ketotestosterone (11-KT), may open a separate path of measurement, which may be more potent. The study was conducted with the objectives to analyze the association of 11-KT and DHT with established markers and with the clinical profile of PCOS patients. Materials and Methods: A case-control study was conducted on 30 newly diagnosed cases of PCOS as per the Rotterdam criteria and 30 age-matched controls. The estimation of testosterone, DHEAS, 11-KT, and DHT was performed by the enzyme-linked immunoassay (ELISA) method. The assessment of biochemical and hormonal parameters was compared and correlated with 11-KT and DHT. Results: Compared to the controls, cases had significantly higher 11-KT (20.81 ± 3.53 vs. 15.83 ± 2.67 nmol/L, P < 0.0001) and DHT (154.39 vs. 71.02 pg/mL, P < 0.0001). 11-KT showed a significant positive correlation with total testosterone (TT) (r = 0.555) and DHEAS (r = 0.501). DHT also showed a significant positive correlation with TT (r = 0.487) and DHEAS (r = 0.52). Conclusion: In conclusion, novel androgen derivatives (11-KT and DHT) hold equivalent evidence for the evaluation of women with PCOS as they are raised in women with PCOS as compared to controls. Moreover, they show a good correlation with the standard markers currently used for PCOS. © 2025 Elsevier B.V., All rights reserved.